Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
Alkermes(ALKS) stock is priced at $48.99, giving the company a market capitalization of 8.22B. It carries a P/E multiple of 127.25.
As of 2026-08-03, Alkermes(ALKS) stock has fluctuated between $48.52 and $50.00. The current price stands at $48.99, placing the stock +1.0% above today's low and -2.0% off the high.
Alkermes(ALKS) shares are trading with a volume of 1.6M, against a daily average of 1.91M.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.
ALKS News
Alkermes plc ((ALKS)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with Ti...
In late July 2026, Alkermes plc reported second-quarter 2026 results showing revenue of US$496.01 million versus US$390.66 million a year earlier, while net inc...
Baird raised the firm’s price target on Alkermes (ALKS) to $58 from $48 and keeps an Outperform rating on the shares. The firm updated its model following Q2 re...
Analyst ratings
72%
of 18 ratingsMore ALKS News
Alkermes (ALKS) reported second quarter 2026 results on July 28, with revenue of US$496.01 million and net income of US$0.501 million, following a period of str...
Alkermes (ALKS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.52 per...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.